Carbaldrate
ALIMENTARY TRACT AND METABOLISM
Also known as: aluminum sodium dihydroxide monocarbonate, dihydroxialumini sodium carbonate, dihydroxyaluminum sodium carbonate, sodium aluminum carbonate hydroxide, sodium aluminum hydroxycarbonate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Carbaldrate is a drug catalogued in DrugCentral. Recorded indications include Gastric Hypersecretory Conditions, Gastroesophageal reflux disease, Heartburn and Hiatal Hernia with Reflux Esophagitis.
- Indications: Gastric Hypersecretory Conditions, Gastroesophageal reflux disease, Heartburn, Hiatal Hernia with Reflux Esophagitis and Indigestion and others.
- ATC code: A02AB04 (Aluminium compounds).
- Molecular formula: CH2AlNaO5; molecular weight 143.99 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (6)
- Gastric Hypersecretory Conditions
- Gastroesophageal reflux disease
- Heartburn
- Hiatal Hernia with Reflux Esophagitis
- Indigestion
- Peptic ulcer
Off-label uses (3)
- Multiple endocrine adenomas
- Stress-Related GI Mucosal Bleeding Prevention
- Systemic mast cell disease
Contraindications (8)
- Aluminum intoxication
- Chronic diarrhea
- Constipation
- Fecal impaction
- Gastrointestinal obstruction
- Hemorrhoids
- Hypophosphatemia
- Kidney disease
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
A02AB04 | ALIMENTARY TRACT AND METABOLISM › DRUGS FOR ACID RELATED DISORDERS › ANTACIDS › Aluminium compounds |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Chronic kidney disease | 961.1 |
Chemical structure
| Molecular formula | CH2AlNaO5 |
|---|---|
| Molecular weight | 143.99 g/mol |
| CAS number | 16482-55-6 |
| InChIKey | — |
| PubChem CID | 118984410 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Carbaldrate used for?
DrugCentral lists the following indications for Carbaldrate: Gastric Hypersecretory Conditions, Gastroesophageal reflux disease, Heartburn, Hiatal Hernia with Reflux Esophagitis, Indigestion and Peptic ulcer.
What is the chemical formula of Carbaldrate?
Carbaldrate has the molecular formula CH2AlNaO5 and a molecular weight of 143.99 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4522 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL3707202 — compound record and bioactivity
- PubChem CID 118984410 — chemical identifiers
- DrugBank DB15825 — drug record
- FDA UNII 6931E8LH07 — substance identity
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.